Group One Trading
FULC icon

Group One Trading’s Fulcrum Therapeutics FULC Stock Holding History

Group One Trading’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23K Sell
3,000
-24,300
-89% -$225K ﹤0.01% 5864
2025
Q4 		$309K Buy
27,300
+27,200
+27,200% +$277K ﹤0.01% 3989
2025
Q3 		$920 Sell
100
-700
-88% -$5.07K ﹤0.01% 8067
2025
Q2 		$5.5K Buy
800
+400
+100% +$2.14K ﹤0.01% 7044
2025
Q1 		$1.15K Sell
400
-55,500
-99% -$204K ﹤0.01% 7145
2024
Q4 		$263K Sell
55,900
-66,200
-54% -$244K ﹤0.01% 3716
2024
Q3 		$436K Buy
122,100
+117,300
+2,444% +$870K ﹤0.01% 2958
2024
Q2 		$29.8K Sell
4,800
-32,400
-87% -$245K ﹤0.01% 4929
2024
Q1 		$351K Buy
37,200
+31,800
+589% +$284K ﹤0.01% 3063
2023
Q4 		$36.5K Sell
5,400
-3,400
-39% -$15.1K ﹤0.01% 5310
2023
Q3 		$39.1K Buy
8,800
+6,700
+319% +$29.3K ﹤0.01% 5333
2023
Q2 		$6.93K Sell
2,100
-1,300
-38% -$3.82K ﹤0.01% 6570
2023
Q1 		$9.69K Buy
3,400
+2,300
+209% +$20.6K ﹤0.01% 5950
2022
Q4 		$8.01K Sell
1,100
-4,300
-80% -$28K ﹤0.01% 6124
2022
Q3 		$44K Buy
5,400
+5,000
+1,250% +$35.8K ﹤0.01% 5503
2022
Q2 		$2K Sell
400
-19,900
-98% -$194K ﹤0.01% 7398
2022
Q1 		$480K Buy
20,300
+15,200
+298% +$215K ﹤0.01% 3864
2021
Q4 		$90K Sell
5,100
-300
-6% -$5.94K ﹤0.01% 5821
2021
Q3 		$152K Buy
+5,400
New +$102K ﹤0.01% 5456

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Group One Trading's FULC Position: Q1 2026 in Review

Group One Trading increased its Fulcrum Therapeutics (FULC) stake by 55% in Q1 2026, buying an estimated $176K and bringing the position to 53,756 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #3517.

Group One Trading first reported a position in FULC in Q3 2021 and has held it in 14 quarters since. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Group One Trading held 53,756 shares of Fulcrum Therapeutics worth $412K as of Q1 2026.
  • Group One Trading bought 19,006 Fulcrum Therapeutics shares in Q1 2026, an estimated $176K.
  • Fulcrum Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3517 holding.
  • Group One Trading first reported a position in Fulcrum Therapeutics in Q3 2021 and has held it in 14 quarters since.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.